What should a pregnant woman with a non-immune rubella titer be advised to do?

A pregnant woman with a non-immune rubella titer should indeed be advised to receive the rubella vaccine postpartum. This recommendation is based on the understanding that vaccination during pregnancy poses a risk to the developing fetus, as rubella can lead to severe congenital defects if the mother contracts the virus while pregnant. Therefore, it is crucial for her to wait until after childbirth to receive the vaccine, ensuring both her protection against future rubella infections and the safety of her baby.

Receiving the vaccination after delivery helps to build her immunity and protect future pregnancies from the potential complications associated with rubella. It's important for healthcare providers to educate women about the necessity of the rubella vaccine in the postpartum period, especially if they are of childbearing age and plan to have more children.

Avoiding all children, getting vaccinated during pregnancy, or ignoring symptoms does not align with the recommended guidelines for handling non-immune status concerning rubella during pregnancy. These alternatives either do not provide adequate protection or could place both the mother and child at unnecessary risk.